Reuters logo
2 个月前
BRIEF-Lannett announces FDA approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml
2017年5月16日 / 上午10点59分 / 2 个月前

BRIEF-Lannett announces FDA approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml

1 分钟阅读

May 16 (Reuters) - Lannett Company Inc

* Lannett announces approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml (0.5 mg/ml)

* Lannett says levocetirizine dihydrochloride oral solution will be manufactured in Carmel, New York by Silarx Pharmaceuticals Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below